NGB2904 |
NGB2904 : Antagonist of DRD3
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| DRD3 |
|
|
Antagonist
10-100 nM
up to 1 uM
Selectivity
In Vitro Selectivity Assessment
Potency Assay Off-Target:
Selectivity within family: greater than 150-fold selectivity over all other dopamine receptor subtyp ...
Potency Cellular
In Vitro
DRD3
Mode of Action: Antagonist
Structure-Activity-Relationship data available? No
DOI Reference: 10.1016/S0960-894X(98)00469-7
In Vivo Validations
Rat
Dose: 10 mg/kg
Route of delivery:
Intravenous
Plasma half life:
2.60 (plasma), 2.48 (brain) h
Systemic clearance:
2.46 ± 0.19 l/h/kg
Area Under the Curve::
3.45 ± 0.21 (plasma), 40.78 ± 1.52 (brain) h·μg/mL
Volume of Distribution at Steady-State:
7.85 ± 1.14 L/Kg
DOI Reference: 10.1124/jpet.109.165084
Dose: 10 mg/Kg
Route of delivery:
Intraperitoneal
Plasma half life:
2.58 ± 1.15 h
Systemic clearance:
13.84 ± 3.51 l/h/kg
Area Under the Curve::
0.66 ± 0.07 (plasma), 4.97 ± 1.40 (brain) h·μg/ml
DOI Reference: 10.1124/jpet.109.165084
Chemical Information
| Molecular Formula | C28H29Cl2N3O |
| SMILEs | O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc2c(c1)Cc1ccccc1-2 |
| InChI | InChI=1S/C28H29Cl2N3O/c29-25-8-5-9-26(27(25)30)33-16-14-32(15-17-33)13-4-3-12-31-28(34)21-10-11-24-22(19-21)18-20-6-1-2-7-23(20)24/h1-2,5-11,19H,3-4,12-18H2,(H,31,34) |
| Molecular weight | 493.17 Da |
| AlogP | 0.0 |
| HBond acceptors | 4 |
| HBond donors | 1 |
| Atoms | 63 |
References
Publications
Vendors
Note: This is not an exhaustive list and does not indicate endorsement by the portal.